Evidence map›Paper›PMID 35337299›Full record

ArticleBMC pulmonary medicine2022

The MLR, NLR, PLR and D-dimer are associated with clinical outcome in lung cancer patients treated with surgery.

Jun Wang, Huawei Li, Ran Xu, Tong Lu, Jiaying Zhao, Pengfei Zhang, Lidong Qu, Shengqiang Zhang, Jida Guo, Linyou Zhang

Abstract read
In one paragraph

Article in BMC pulmonary medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Preparation and In vitro/In vivo Evaluation of Fingolimod hydrochloride Loaded Polymeric Mixed Nano-Micelles for Treatment of Multiple Sclerosis.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2025
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jun WangDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Huawei LiDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Ran XuDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Tong LuDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jiaying ZhaoDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Pengfei ZhangDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Lidong QuDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Shengqiang ZhangDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jida GuoDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Linyou ZhangDepartment of Thoracic Surgery, The Second Affiliated Hospital of Harbin Medical University, Harbin, China. lyzhang@hrbmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study objective was to investigate the use of peripheral blood biomarkers as predictors of patient survival. The aim of this study was to identify the baseline peripheral blood biomarkers associated with clinical outcome in patients with early lung cancer (stage I-II) treated with surgery.

methodsWe included and analysed data from 376 patients with early-stage lung cancer who underwent a standard lobectomy. Univariate and multivariate Cox regression analyses were performed on all patients to assess the relationships between progression-free survival (PFS) and overall survival (OS) and the peripheral blood biomarker metrics measured before surgical treatment. The peripheral blood parameters included monocyte-to-lymphocyte ratio (MLR), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and dimeric fibrin fragment D (D-dimer).

resultsAfter univariate Cox regression analysis, low MLR, low NLR, low PLR and low D-dimer values were significantly associated with both better OS and PFS (all p < 0.05). In multivariate Cox regression analysis, a low MLR was significantly and independently associated with both better overall survival and better progression-free survival (both p <0.05). A low D-dimer level was significantly and independently associated with better overall survival (p <0.05). Furthermore, the categorization of patients according to the number of factors with favourable results revealed that those without favourable results had significantly worse outcomes than that of those patients with at least one.

conclusionA baseline signature of low MLR, low NLR, low PLR, and low D-dimer values was associated with a better survival outcome for patients treated with surgery. Patients with more favourable results had better survival outcomes.

Indexed as

Lung NeoplasmsNeutrophilsFibrin Fibrinogen Degradation ProductsHumansLymphocytesMonocytesPrognosisFibrin Fibrinogen Degradation Productsfibrin fragment DD-dimerEarly lung cancerMLRNLRPeripheral blood biomarkersPLR

Identifiers

PMID35337299
PMCPMC8957174

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.